MALLINCKRODT PHARMACEUTICALS LIMITED

Company number 09780382

Date	Type	Description	View / Download
05 May 2020	MR01	Registration of charge 097803820009, created on 1 May 2020	(29 pages)
04 May 2020	MR01	Registration of charge 097803820008, created on 4 May 2020	(49 pages)
04 May 2020	MR01	Registration of charge 097803820007, created on 4 May 2020	(37 pages)
27 Feb 2020	TM02	Termination of appointment of Tmf Corporate Administration Services Limited as a secretary on 27 February 2020	(1 page)
02 Jan 2020	AD02	Register inspection address has been changed from 8th Floor 20 Farringdon Street London EC4A 4AB United Kingdom to 3 Lotus Park the Causeway Staines-upon-Thames TW18 3AG	(1 page)
02 Jan 2020	AD04	Register(s) moved to registered office address 3 Lotus Park the Causeway Staines upon Thames TW18 3AG	(1 page)
19 Dec 2019	MR01	Registration of charge 097803820006, created on 13 December 2019	(28 pages)
17 Dec 2019	MR01	Registration of charge 097803820005, created on 6 December 2019	(29 pages)
12 Dec 2019	MR01	Registration of charge 097803820004, created on 6 December 2019	(43 pages)
12 Dec 2019	MR01	Registration of charge 097803820003, created on 6 December 2019	(36 pages)
09 Dec 2019	MR01	Registration of charge 097803820002, created on 6 December 2019	(37 pages)
24 Sep 2019	CS01	Confirmation statement made on 15 September 2019 with updates	(5 pages)
24 Sep 2019	CH01	Director's details changed for Mr Josh Schafer on 15 September 2019	(2 pages)
24 Sep 2019	CH01	Director's details changed for Mr Mark Trudeau on 15 September 2019	(2 pages)
13 Aug 2019	AD02	Register inspection address has been changed from 5th Floor 6 st. Andrew Street London EC4A 3AE United Kingdom to 8th Floor 20 Farringdon Street London EC4A 4AB	(1 page)
07 Aug 2019	CH04	Secretary's details changed for Tmf Corporate Administration Services Limited on 5 August 2019	(1 page)
29 May 2019	AA	Full accounts made up to 28 December 2018	(27 pages)
07 Mar 2019	SH01	Statement of capital following an allotment of shares on 28 February 2019 USD 5,962,038,120.00	(4 pages)
06 Mar 2019	RESOLUTIONS	Resolutions RES14 ‐ Capitalisation of usd 5961803016 and usd 135000 28/02/2019	(1 page)
28 Feb 2019	SH20	Statement by Directors	(1 page)
28 Feb 2019	SH19	Statement of capital on 28 February 2019 USD 100,104	(3 pages)
28 Feb 2019	CAP-SS	Solvency Statement dated 28/02/19	(1 page)
28 Feb 2019	RESOLUTIONS	Resolutions RES13 ‐ Cancellation of share premium 28/02/2019 RES06 ‐ Resolution of reduction in issued share capital	(1 page)
18 Jan 2019	CH01	Director's details changed for Ms Stephanie Dorn Miller on 1 August 2018	(2 pages)
22 Oct 2018	SH01	Statement of capital following an allotment of shares on 28 September 2018 USD 100,104	(3 pages)